Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
3.780
+0.060 (1.61%)
Jul 16, 2025, 10:23 AM - Market open
UPC Revenue
Universe Pharmaceuticals INC had revenue of $9.15M in the half year ending March 31, 2025, a decrease of -50.44%. This brings the company's revenue in the last twelve months to $19.29M, down -27.81% year-over-year. In the fiscal year ending September 30, 2024, Universe Pharmaceuticals INC had annual revenue of $23.02M, down -28.74%.
Revenue (ttm)
$19.29M
Revenue Growth
-27.81%
P/S Ratio
0.04
Revenue / Employee
$85,747
Employees
225
Market Cap
2.13M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
UPC News
- 4 months ago - Universe Pharmaceuticals INC Announces Share Consolidation - GlobeNewsWire
- 5 months ago - Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report - GlobeNewsWire
- 5 months ago - Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request - GlobeNewsWire
- 7 months ago - Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC) - GlobeNewsWire
- 9 months ago - Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - GlobeNewsWire
- 10 months ago - Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024 - GlobeNewsWire
- 1 year ago - Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results - PRNewsWire
- 2 years ago - Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares - GlobeNewsWire